Status:
RECRUITING
Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Diabetes Mellitus Type 2 in Obese
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
In patients with type 2 diabetes, Roux-en-Y gastric bypass (RYGB), which excludes a portion of the stomach and the proximal intestine from the alimentary circuit, improves glucose metabolism more rapi...
Eligibility Criteria
Inclusion
- BMI ≥ 35 kg/m2
- All patient with type 2 diabetes
- Patients who were candidates for obesity surgery in accordance with French recommendation
Exclusion
- Severe cognitive or mental disorders
- patient who have already undergone obesity surgery
- Severe and non-stabilised eating disorders
- The likely inability of the patient to participate in lifelong medical follow-up
- Alcohol or psychoactive substances dependence
- The absence of identified prior medical management of obesity
- Diseases that are life-threatening in the short and medium term;
- Contraindications to general anaesthesia.
Key Trial Info
Start Date :
June 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT03821636
Start Date
June 16 2019
End Date
June 1 2026
Last Update
December 23 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Amiens Picardie
Amiens, France
2
Ch Boulogne-Sur-Me
Boulogne-sur-Mer, France, 62321
3
Hop Claude Huriez Chu Lille
Lille, France, 59037
4
Ch de Valenciennes
Valenciennes, France